Immunodiagnostic Systems SA
68.9 FTEImmunodiagnostic Systems reported revenue of €12.8m for the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026), with 68.9 full-time equivalents.
The score of Immunodiagnostic Systems shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +50 % Equity +22 % Total assets +19 % Headcount (avg FTE) +6 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immunodiagnostic Systems's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €12.8m | ||||
| Net result | 577,381 € | ||||
| Equity | €7.38m | ||||
| Cash | 474,595 € | ||||
| EBITDA | 920,570 € | ||||
| Total assets | €10.7m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 12 Jun 2023
- Year ended 31 Mar 2021filed on 13 Sep 2021
Immunodiagnostic Systems's financial analysis
- Solvency69.0%sector median: 43.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immunodiagnostic Systems
Immunodiagnostic Systems's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0436.921.949
- VAT number
- BE0436921949
- Peppol
- Registered · 0208:0436921949 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Feb 1989
- Registered office
- 4000 Liège
- Size
- Medium · 68.9 FTE
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Manufacture of other chemical products n.e.c. (NACE 20590)
Immunodiagnostic Systems (SA) has been based in Liège since 1989, active in: manufacture of other chemical products n.e.c.. For 2025, it reports revenue of €12.8m, a net profit of 577,381 € and equity of €7.38m. With 68.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 69.0%, above the median of its sector (43.8%).
Companies similar to Immunodiagnostic Systems
Companies in the same business, of comparable size and area, outside its group.
- Sartorius Xpress Biologics Manufacture of basic pharmaceutical products Herstal · balance sheet €10.9m
- Univercells Technologies Manufacture of other chemical products n.e.c. Nivelles · balance sheet €16.2m
- Unisensor Manufacture of basic pharmaceutical products Seraing · balance sheet €19.2m
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
- Phoenix Biosciences Manufacture of pharmaceutical preparations Nivelles · balance sheet €8.11m
- Shant Biotech Manufacture of basic pharmaceutical products Tubize · balance sheet €11.0m
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- Cepheid Benelux Manufacture of communication equipment Ghent · balance sheet €10.7m
Frequently asked questions about Immunodiagnostic Systems
What is the revenue of Immunodiagnostic Systems?
According to the 2025 annual accounts filed with the NBB, the revenue of Immunodiagnostic Systems amounts to 12,832,055 €.
What is the VAT number of Immunodiagnostic Systems?
In Belgium, the VAT number is the company number prefixed with BE: BE0436921949 for Immunodiagnostic Systems, if the company is VAT-registered. Its company number (CBE) is 0436.921.949.
Where is the registered office of Immunodiagnostic Systems?
According to the CBE register, the registered office of Immunodiagnostic Systems is in 4000 Liège.
What is the equity of Immunodiagnostic Systems?
At the close of the 2025 financial year, the equity of Immunodiagnostic Systems amounts to 7,378,376 €, a solvency of 69.0% of total assets.
How many people work at Immunodiagnostic Systems?
68.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Immunodiagnostic Systems?
The register lists 3 active mandates at Immunodiagnostic Systems. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immunodiagnostic Systems
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →